Patient Support Programs in Saudi Arabia & the GCC: An End-to-End Guide

A PSP is a structured service that supports patients through their treatment journey. Typical services include education, nurse or pharmacist contact, device training, reminders, caregiver support, care coordination and feedback collection.

A PSP is not a promotional tool. It must be designed around patient need, kept clinically neutral and governed so that it does not influence prescribing. Where it supports a specific therapy, it should follow approved information and the treating physician's plan.

Map the journey from first symptom to long-term management and mark the points where patients most often struggle. The details vary by condition, but the patterns repeat.

Talk to patients, caregivers, nurses and physicians to confirm which barriers matter most for your condition, rather than assuming.

Select the model by patient complexity, geography, institutional preferences and budget. Most programmes begin with a pilot at a small number of centres.

1. Enrolment and consent. A simple process in the patient's language, with clear explanation of what the programme offers and how data will be used.
2. Personalised onboarding. A call or visit that explains the plan, demonstrates devices and answers questions.
3. Education. Short, plain-language materials in Arabic and English, in several formats, such as video, illustration and printed guides.
4. Ongoing contact. Scheduled check-ins by phone, message or visit, with a named nurse or pharmacist where possible.
5. Adherence support. Reminders and practical problem-solving, without pressure or judgement.
6. Caregiver support. Guidance for family members who help with daily care.
7. Care coordination. A clear channel between the programme and the treating team, with the patient's consent.
8. Feedback and insight. Structured collection of patient experience and barriers, shared in anonymised form with medical and brand teams.

• Family at the centre. Offer caregiver sessions and materials, while respecting the patient's control over what is shared.
• Language and tone. Write in clear Arabic and English, with warmth and respect. Use dialect-aware tone where suitable, and test content with patients.
• Privacy and modesty. Provide private spaces, gender-appropriate staff where requested and discreet communication.
• Seasonal awareness. Plan for Ramadan, Hajj and Umrah periods, school holidays and summer travel, when routines shift.
• Geography. Use remote contact and delivery coordination where patients live far from specialist centres.

Digital tools extend a nurse's reach without replacing the human relationship. Useful elements include a messaging flow for reminders and short education, a bilingual video library, a secure channel for questions, a caregiver view with patient-approved information and a dashboard for clinicians with consented engagement signals. Keep the experience light, make human help easy to reach and collect only the data you need. Review hosting, access controls and vendor contracts against Saudi and UAE data-protection requirements.

PSP staff may be the first to learn about side effects or product concerns, so the programme needs a robust process:

• Train every team member to recognise and record adverse events and product complaints.
• Define how and when reports reach the pharmacovigilance team.
• Direct patients with medical concerns to appropriate clinical care.
• Keep education neutral, accurate and aligned with approved information.
• Separate the programme from sales targets and train staff on boundaries.
• Document consent, data flows and retention, and review them regularly.

Involve Medical, Regulatory, Legal and Data Protection teams from the first design workshop.

Agree definitions and data sources before launch. Report in a way that protects privacy, and use findings to improve the service, not only to prove its value.

Consider a programme for a rare condition where few specialists exist and patients may travel long distances. A central nurse hub provides a named contact for each family. Patients receive a welcome call, a bilingual guide and, where appropriate, a home or clinic session to learn administration or care routines. Caregivers join a monthly online session led by a nurse and a dietitian. The hub shares anonymised insights on barriers, such as travel difficulty and school absences, with the medical team, which uses them to support better coordination with hospitals. The programme's value lies in the continuity and confidence it gives families.

• Designing technology before understanding the patient need
• Treating the PSP as a marketing tool and eroding trust
• Excluding caregivers and physicians from the design
• Launching without consent, governance or a pharmacovigilance process
• Measuring only enrolment, not persistence and experience

In Saudi Arabia, a PSP should be designed around the patient's real pathway between government hospitals, private groups and community pharmacies. Offer Arabic-first nurse and pharmacist calls, WhatsApp-friendly reminders where approved, and home or clinic visits in Riyadh, Jeddah and Dammam before scaling to other regions. Involve family caregivers by design, follow the Personal Data Protection Law (PDPL) for consent and data storage, and agree adverse-event reporting routes with the pharmacovigilance team before launch.

See how Spectra supports this in the Kingdom through our patient support programmes, patient activation programmes services, our Saudi Arabia market page, and the related guide patient support programs saudi arabia.

Who can run a patient support program in Saudi Arabia? Usually a pharma company working with a specialist PSP provider and licensed nurses or pharmacists, with Medical, Regulatory, Legal and pharmacovigilance sign-off on the model.

What is a patient support program? A structured service that educates and supports patients and caregivers through diagnosis, treatment and long-term management, with the aim of improving understanding, adherence and outcomes.

Who should deliver a PSP? Trained nurses, pharmacists, dietitians and coordinators, supported by digital tools and aligned with the treating physician.

How do you keep a PSP compliant? Design it as a neutral patient service, involve Medical, Regulatory and Legal early, follow data-protection law and apply a clear pharmacovigilance process.

How long does it take to launch a PSP? A focused pilot can often be prepared in about three months, depending on approvals, partners and the complexity of the therapy.

Spectra Solutions MEA designs and delivers patient support programmes and digital health ecosystems across the GCC. Start the conversation.

Frameworks, timelines and KPIs in this guide are starting points to adapt, not benchmarks. Add current figures from official sources before quoting statistics. Regulatory references are general; Medical, Regulatory and Legal teams should confirm SFDA, PDPL and institutional requirements for each programme.